Genome-wide CRISPR screens identify the EXO1-CAF-1 pathway suppressing R-loop-associated DNA damage

Alexandra Nusawardhana1, Anastasia Hale1, Joshua Straka1

  • 1Department of Molecular and Precision Medicine, The Pennsylvania State University College of Medicine, Hershey, PA 17033, United States.

Nucleic Acids Research
|March 17, 2026
PubMed

Insights

The exonuclease EXO1 is crucial for repairing DNA damage from chemotherapy drugs like cisplatin. Its absence, along with the histone chaperone CAF-1, leads to R-loop accumulation and DNA damage, impacting genomic stability.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cellular Biology

Background:

  • DNA repair mechanisms are essential for maintaining cellular homeostasis and responding to genotoxic stress.
  • EXO1 is a 5'-3' exonuclease involved in various DNA biological processes.
  • Understanding EXO1's function is critical, especially in the context of chemotherapeutic treatments.

Purpose of the Study:

  • To identify genes affecting proliferation and cisplatin sensitivity in EXO1-deficient cells using CRISPR screening.
  • To elucidate the specific roles of EXO1 in repairing DNA damage induced by genotoxic agents.
  • To investigate the functional relationship between EXO1 and other DNA maintenance pathways, including R-loop suppression.

Main Methods:

  • CRISPR loss-of-function genome-wide screening to identify essential genes in EXO1-deficient cells.
  • Analysis of genetic networks to understand differential regulation of cisplatin sensitivity.
  • Synthetic lethality screens to uncover genetic interactions, specifically with histone chaperone CAF-1.
  • Mechanistic studies investigating the recruitment and function of EXO1 and CAF-1 in R-loop suppression.

Main Results:

  • EXO1 is critical for the repair of cisplatin-induced DNA damage, a role not observed in wildtype cells.
  • A synthetic lethal interaction was identified between EXO1 and the histone chaperone CAF-1.
  • EXO1 and CAF-1 are independently recruited to R-loops and function synergistically to suppress them.
  • Concomitant loss of EXO1 and CAF-1 leads to R-loop accumulation and DNA damage, even without exogenous genotoxic treatment.

Conclusions:

  • EXO1 plays a vital role in the DNA damage response pathway, particularly in repairing chemotherapy-induced damage.
  • The combined action of EXO1 and CAF-1 is crucial for preventing R-loop accumulation and maintaining genomic stability.
  • Disruptions in the EXO1-CAF-1 pathway can lead to significant R-loop-associated DNA damage, highlighting a novel mechanism of genomic instability.

Related Concept Videos

CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
2.5K
CRISPR and crRNAs02:53

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
19.5K
Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
65.1K